Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
10.10
+0.12 (1.20%)
Apr 25, 2025, 9:30 AM EDT - Market open

Zenas BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
422342--
Enterprise Value
67-44--
Last Close Price
9.988.19--
Debt / Equity Ratio
0.000.000.870.03
Asset Turnover
0.020.020.70-
Quick Ratio
6.126.122.442.59
Current Ratio
6.216.212.572.64
Return on Equity (ROE)
-93.22%-93.22%-102.89%-
Return on Assets (ROA)
-46.76%-46.76%-23.77%-
Return on Capital (ROIC)
-57.07%-57.07%-35.79%-
Buyback Yield / Dilution
-762.01%-762.01%-2.61%-
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q